Guest guest Posted October 31, 2003 Report Posted October 31, 2003 : Double Payment -taxes pay for drug research, and then we front the money again at the counter > > Double Payment > by Robert Reich > Our taxes pay for drug research, and then we front the money again at > the counter. > 1665e6c.jpg > Robert B. Reich is the Maurice B. Hexter Professor of Social and Economic > Policy at Brandeis University, and was the Secretary of Labor under former > President Bill Clinton. > > > Prescription drugs are the largest single health-care expense for most > Americans, especially seniors. And drug prices are rising at a whopping 17 > percent a year, more than four times faster than inflation. Pharmaceutical > prices are higher in the United States than in any other country in the > world. Thats why increasing numbers of Americans are filling their > prescriptions in Canada. > > Its also why politicians of all stripes are eager to put their names on > legislation providing prescription-drug benefits. Whatever emerges from > this Congress is likely to be a complex and pricy sheme that will cost > American taxpayers upwards of $400 billion over the next decade. > > Drug companies say all this money is necessary because research and > development on new drugs is hugely expensive. Bringing a new drug to market > costs between $500 and $800 million. And we all benefit from what these new > drugs can do. > > But pharmaceutical companies dont own up to the fact that you and I are > already paying twice for new drugs. Not only do we pay high and > rapidly-escalating purchase prices for them. We also pay through our taxes. > You see, a portion of federal tax revenues goes to support drug research. > > For example, eight of the 10 most popular drugs produced by one of Americas > largest pharmaceutical companies were developed at the National Institutes > of Health, which is a huge taxpayer-funded research complex. Most of todays > anti-cancer drugs also have come courtesy of the National Institutes of > Health. > > Drug companies do research and development, of course. But they devote only > 12-and-a-half percent of their incomes to it, on average. They spend more > than twice that on advertising and marketing. Much of the rest is profit. > And drug companies are very, very profitable. During the recent downturn, > the nations top 10 pharmaceutical companies reported a 33 percent increase > in profits. > http://www.tompaine.com/feature2.cfm/ID/9258 Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.